Stocks
Atara Biotherapeutics (ATRA) EBITDA US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| EBITDA, bln rub | ? | -331.1 | -222.3 | -266.0 | -75.7 | 38.6 | -5.54 | |
| Changes by years, y/y, % | +10% | -33% | +20% | -72% | -151% | |||
Atara Biotherapeutics. EBITDA US GAAP, bln rub
Atara Biotherapeutics. EBITDA US GAAP, changes, %
Atara Biotherapeutics. EBITDA US GAAP, sum by quarters, bln rub
Atara Biotherapeutics (ATRA) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | 40.8 | 3.60 | -3.33 | -2.46 | -3.29 | -5.54 | |
| Changes by years, y/y, % | -240% | -122% | -83% | -77% | -108% | |||
| Changes by quarters, q/q, % | -485% | -91% | -193% | -26% | +33% | |||
